EDUCATION AND TRAINING

Masters, Biotechnology (Panjab University, India)
PhD (Indian Institute of Technology, Roorkee, India)

BIOGRAPHY

Ramanjit received her PhD from the Indian Institute of Technology, Roorkee in India, where she identified and characterized various antiviral molecules against alphaviruses, including chikungunya and aura viruses. Ramanjit joined the Department of Microbiology at NYU Langone Medical Center as a postdoctoral fellow in the lab of Dr Nathaniel Landau, where she worked on characterizing the antiviral activity of interferon-inducible host protein, receptor transporter protein 4 (RTP4), against coronaviruses, including SARS-CoV-2 and HCoV-OC43. She also explored the lentiviral vector-based dendritic cell vaccine approach against lymphocytic choriomeningitis virus (LCMV)-induced encephalitis in the mouse model. Ramanjit is a recipient of the Leon Levy Neuroscience Fellowship, which allowed her to investigate the basis of neurodegenerative disease using gene expression studies.

Ramanjit joined tenOever Lab in January 2023 as a Research Scientist. She is currently studying the role of an archaeal kink-turn binding protein in regulating the splicing biology of influenza A virus. In another project, she is investigating ADAR1-mediated RNA editing and its modulation by RNA-binding proteins.